NuRepress: Inferring Transcriptional Repressors from Phased Nucleosome Architecture
Genes · 18.04.2026 · 17 (4) · 480
DOI: 10.3390/genes17040480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 18.04.2026. Verfasst von Qianming Xiang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Technology, Peking University Health Science Center, Beijing 100191, China. Hauptthemen laut MEDLINE: Nucleosomes, Repressor Proteins, Computational Biology. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Project of China.
Abstract (Originalsprache)
Background
The systematic identification of transcriptional repressors remains challenging, as current inference frameworks are predominantly optimized for accessible chromatin, leaving regulatory signals embedded within repressive domains undercharacterized.
Methods
Here, we present NuRepress, a computational framework that predicts candidate transcriptional repressors by integrating repressive chromatin architecture, functional signatures, and transcriptional outcomes. NuRepress first identifies well-phased nucleosome arrays within repressive chromatin. These arrays are treated as discrete structural units that capture characteristic local chromatin organization associated with regulatory activity. Since distinct Tn5 cut signal patterns often imply divergent regulatory functions, the framework stratifies these arrays into potential functional subtypes. By synthesizing the quantified repressive efficacy of each subtype with spatial motif enrichment and observed transcriptional dynamics, NuRepress systematically prioritizes and ranks candidate repressors.
Results
Our analysis indicated that well-phased nucleosome arrays exhibited accessibility-defined organizational patterns with distinct repressive efficacies, and that these patterns were also observed across species, suggesting that the structural principles captured by NuRepress might extend beyond one specific biological system. Positional motif analysis revealed that distinct TFs exhibited different spatial preferences relative to well-phased nucleosome arrays, suggesting scale-specific preferences for their interactions with these organized chromatin structures. When applied to pancreatic cancer progression, NuRepress identified changes in nucleosome organization associated with stage-specific transcriptional remodeling, highlighting candidate repressors of key oncogenic drivers.
Conclusions
NuRepress establishes a structure-aware strategy for repressor inference that extends regulatory genomics beyond accessibility-centered paradigms. By linking well-phased nucleosome organization to transcriptional outcomes, it provides a principled framework for dissecting transcriptional repression across diverse biological settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Technology, Peking University Health Science Center, Beijing 100191, China.
- Biomedical Engineering Department, Institute of Advanced Clinical Medicine, Peking University, Beijing 100191, China.
- Department of Dermatology and Venerology, Peking University First Hospital, Beijing 100191, China.
- State Key Laboratory of Molecular Oncology, Peking University International Cancer Institute, Beijing 100191, China.
Förderung
- National Key Research and Development Project of China
Zitieren
APA
Xiang, Q., & Lai, B. (2026). NuRepress: Inferring Transcriptional Repressors from Phased Nucleosome Architecture. Genes, 17(4), 480. https://doi.org/10.3390/genes17040480
Vancouver
Xiang Q, Lai B. NuRepress: Inferring Transcriptional Repressors from Phased Nucleosome Architecture. Genes. 2026;17(4):480. doi:10.3390/genes17040480
BibTeX
@article{Xiang2026,
author = {Xiang, Qianming and Lai, Binbin},
title = {NuRepress: Inferring Transcriptional Repressors from Phased Nucleosome Architecture},
journal = {Genes},
year = {2026},
volume = {17},
number = {4},
pages = {480},
doi = {10.3390/genes17040480}
}
EUVIMED